Table 3.
Pathological types in Non-diabetic kidney disease
| Type | All (n = 244) | NDKD Group (n = 112) | MIX Group (n = 14) |
|---|---|---|---|
| IgA N, n( %) | 69 (28.28) | 59 (52.68) | 10 (71.43) |
| MN, n( %) | 23 (9.43) | 21 (18.75) | 2 (14.29) |
| MCD, n( %) | 6 (2.46) | 6 (5.36) | 0 |
| MsPGN, n( %) | 5 (2.05) | 5 (4.46) | 0 |
| Hypertensive nephropathy, n( %) | 5 (2.05) | 4 (3.57) | 1 (7.14) |
| HSPN, n( %) | 5 (2.05) | 5 (4.46) | 0 |
| PsG, n( %) | 3 (1.23) | 3 (2.68) | 0 |
| Amyloid nephropathy, n( %) | 4 (1.64) | 3 (2.68) | 1 (7.14) |
| ANCA relative glomerulonephritis, n( %) | 4 (1.64) | 4 (3.57) | 0 |
| FSGS, n( %) | 3 (1.23) | 3 (2.68) | 0 |
| LN, n( %) | 3 (1.23) | 3 (2.68) | 0 |
| MPGN, n( %) | 1 (0.41) | 1 (0.89) | 0 |
| C3G, n( %) | 1 (0.41) | 1 (0.89) | 0 |
| OaG, n( %) | 1 (0.41) | 1 (0.89) | 0 |
The data were presented as the frequency (%). NDKD Non-diabetic kidney disease; MIX Group, NDKD superimposed DKD, IgA N IgA nephropathy, MN Membranous nephropathy, MCD Minimal change disease, MsPGN Mesangial proliferative glomerulonephritis, HSPN Henoch-Schonlein purpura nephritis, PsG Proliferative-sclerosing glomerulonephritis, FSGS Focal segmental glomerulosclerosis, LN Lupus nephritis, MPGN Membranoproliferative glomerulonephritis, C3G C3 glomerulopathy, OaG Obesity-associated glomerulomegaly. Six patients were diagnosed as IgA N combined with MN, and one patients was diagnosed as MCD combined with hypertensive nephropathy